Helicobacter

Papers
(The H4-Index of Helicobacter is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta‐analysis60
PPI‐amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta‐analysis55
Review: Epidemiology of Helicobacter pylori47
Review: Extragastric diseases andHelicobacter pylori41
A meta‐analysis of the association between Helicobacter pylori infection and risk of atherosclerotic cardiovascular disease40
The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults38
A comparative study of 14‐day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first‐line Helicobacter pylori infection eradication: A randomized38
Review: Pathogenesis of Helicobacter pylori infection38
Changes in the human gut microbiota composition caused by Helicobacter pylori eradication therapy: A systematic review and meta‐analysis34
Review: Diagnosis of Helicobacter pylori infection34
PCR analysis and specific immunohistochemistry revealing a high prevalence of non‐Helicobacter pylori Helicobacters in Helicobacter pylori‐negative gastric disease patients in Japan: Hig34
Time trends and other sources of variation in Helicobacter pylori infection in mainland China: A systematic review and meta‐analysis33
Review – Treatment of Helicobacter pylori infection 202032
Optimization of vonoprazan‐amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study31
Helicobacter pylori induced reactive oxygen Species: A new and developing platform for detection29
Effects of non‐viableLactobacillus reutericombining with 14‐day standard triple therapy onHelicobacter pylorieradication: A randomized double‐blind placebo‐controlled trial28
Helicobacter pylori “Test‐and‐Treat” strategy with urea breath test: A cost‐effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain—Results of25
PPI‐amoxicillin dual therapy four times daily is superior to guidelines recommended regimens in the Helicobacter pylori eradication therapy within Asia: A systematic review and meta‐analysis24
Gastric microbiota and Helicobacter pylori in Indonesian population22
The efficacy of Helicobacter pylori eradication in diabetics and its effect on glycemic control: A systematic review and meta‐analysis22
Re‐assessment of the disk diffusion technique for routine antimicrobial susceptibility testing for Helicobacter pylori22
Evaluation of the Allplex™ H pylori and ClariR PCR Assay for Helicobacter pylori detection on gastric biopsies22
0.050110101699829